Universal, no-cost coverage for the drug mifegymiso (also known as RU-486) commenced on 15 January 2018. Mifegymiso, an alternative to surgical abortion, is a combination of mifepristone and... Read More
News
Fecal immunochemical testing (FIT), part of the early screening process for colon cancer, resumed on 15 December 2017 following a temporary suspension. Eligible patients can pick up FIT kits from any... Read More
Creating a robust privacy management program can seem daunting, and putting such a program in place can sometimes take a back seat to providing patient care. Under current privacy legislation,... Read More
Medical errors can be costly for both patient and hospital. As defined by the Joint Commission (www.jointcommission.org/assets/1/18/Hot_Topics_Transitions_of_Care.pdf), in order to keep patients safe... Read More
The BCMJ is pleased to introduce our newest Editorial Board member, Dr Yvonne Sin. Dr Sin is a second-year UBC family practice resident who intends to practise full-service family... Read More